Canada
Puerto Rico
USA
Belgium
France
UK
IndiaOverview
Utilizing Real World Evidence Effectively and Efficiently to Accelerate Drug Discovery Process
Real-world data (RWD) and real-world evidence (RWE) are transforming healthcare decision-making by providing insights beyond traditional clinical trials. Our innovative RWD/E offering addresses critical challenges in data acquisition, analysis, and application across the healthcare ecosystem.
80%
Life Sciences data is
unstructured
unstructured
30-40%
Data is inaccurate or missing values
100s
Of potential sources are to be considered
$2M+ per study
High cost of RWE Studies
Leveraging advanced technologies such as AI and ML, our comprehensive solution abstracts high-quality data from diverse sources including electronic health records, claims databases, and patient registries. Rigorous data governance and standardization processes ensure the reliability and relevance of
the generated evidence.
the generated evidence.
Innova Brings Together all the Right Ingredients in the Right Mix to Tackle the RWE Challenges
Domain Expertise in LS & RWE
- Structured approach to RWD&E Analysis
- Capability & talent pool on RWE (Epidemiology / HEOR / Biostatisticians / Medical Specialists / Medical Writers etc.)
- Collaboration across multiple RWE partners
Data Science & Data Engineering
- Robust Data & Analytics practice
- Ready to deploy pool of data scientists & engineers
- Experience in multiple enterprise-level complex data platforms
Engagement
- Flexibility in engagement and support requirements
- Fully managed team engaged in T&M / FP / Outcomes based
- Tap into rich pool of resources for ad-hoc resource needs
Accelerators & Platforms
- AEM (Accelerated Engineering Methodology) of delivery
- iDSP (Intelligent Data Science Platform) to be leveraged
Our RWD/E Offerings
Structured approach to RWD/E Analysis
Capability & talent pool on RWD/E
Collaboration across multiple RWD vendors
Flexibility in engagement and support requirements
Unlock Insights from Real-World Data to Drive Research, Compliance, and Patient Outcomes.
Experience with Data Sources
Our Partnerships
Use Cases
RWE Benefits for a Biopharma Company
- 30% reduction in clinical study costs through evidence-based protocol design.
- 20-25% reduction in the cost of Real-World Evidence (RWE) analysis.
Patient Care Management
- Decreased hospitalizations through personalized fluid management.
- Reduced progression of cardiovascular disease (CVD) through improved management of hypertension.
Insights
BLOG
DIA 2025: Real Innovation, Real Momentum for Life Sciences
Real-World Data in Life Sciences: From Possibility to Proof
Connect with us to know more about our RWD/E Solutions and how we augment your healthcare decision making.